Since their introduction, GLP-1 medications have rapidly gained popularity for their effectiveness in helping people manage ...

Obesity is one of the greatest burdens of global public health. One major factor that drives obesity is excessive fat ...

The survey showed that while most of the doctors didn’t have top-of-mind awareness of oral semaglutide’s upcoming FDA ...

Some weight-loss and diabetes drugs can treat obesity when combined with exercise, a healthy diet, and counseling, according to WHO's first guidance on these medicines. The recommendations come amid ...

Bank of America sees Eli Lilly's obesity drug growth underestimated, forecasting $3 billion Orfoglipron revenue by 2026 as new therapies expand global market leadership.

Obesity accelerates the rise of Alzheimer’s-related blood biomarkers far more rapidly than previously recognized. Long-term imaging and plasma data show that obese individuals experience much faster ...

The larger risk reductions were not explained by changes in LDL cholesterol, suggesting something else is at play.

Obesity is independently associated with an increased prevalence of tinnitus, according to a study published online Nov. 2 in ...

The World Health Organization (WHO) has released an evidence-informed guideline on the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity among adults. The guideline was ...

A study by researchers at the Federal University of São Carlos (UFSCar) in Brazil, in partnership with University College ...

Lilly’s closely watched retatrutide spurred as much as 29% weight loss in a Phase 3 study, a finding that is “raising the bar ...

Please provide your email address to receive an email when new articles are posted on . The effects of childhood obesity can have negative impacts into adulthood if left untreated. Fox advises ...